Rituximab in glomerular diseases: a case series and narrative review.
Inês DuarteJoão OliveiraCristina OutereloIolanda GodinhoMarta PereiraPaulo FernandesSofia JorgeJoana GameiroPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2021)
The efficacy of RTX in treating different types of immune-mediated GD has been demonstrated with different response rates, but an overall safe profile. In our case series, the results are also encouraging. Longitudinal studies are needed to better understand the effect of RTX in GD.